Recently, the R & D center of Phoenix Bridge Holdings (Beijing) Co., Ltd., a subsidiary of Phoenix Bridge Group, was recognized jointly by Beijing Municipal Science & Technology Commission, Administrative Commission of Zhongguancun Science Park as one of the first group of Beijing foreign-funded R & D centers in 2022. This marks another major milestone in the implementation of the development strategy of Phoenix Bridge Group focusing on scientific and technological innovation.

The core R & D team of Phoenix Bridge (Beijing) R & D center includes senior experts and consultants at home and abroad, such as famous university professors, British Royal Academicians and high-end R & D talents. At present, the main research fields of Phoenix Bridge (Beijing) R & D center are in medical and optical fields. Among them, based on molecular diagnosis technology and microfluidic biochip as carrier, the research and development of the prototype of POCT (real-time detection) equipment applied in the clinical front line has been completed. It is planned to realize product implementation in China in 2024 and start commercial and large-scale operation. The strong overseas R & D capabilities and leading R & D products of Phoenix Bridge (Beijing) R & D center have been recognized by the accreditation agencies.

It will provide a series of incentives and various measures for the first group of recognized foreign-funded R & D centers. It will provide favorable policies for the recruitment of high-end domestic and foreign R & D personnel and the import and export of R & D equipment and raw materials. The policies will also continue to promote the growth of Phoenix Bridge R & D center for a long time.

Phoenix Bridge Group will take Phoenix Bridge (Beijing) R & D center as the carrier for the transformation of high-tech R & D achievements. With the help of domestic policies, markets, talents, fields, facilities and other advantageous resources, Phoenix Bridge Group will integrate internationally leading R & D talents, cutting-edge scientific and technological resources and capital resources, and be empowered by Phoenix Bridge capital to accelerate the development of research and the transformation of achievements through the dual drive of investment + R & D. We will strive to build a structureof "expanding and consolidating overseas R & D fields and teams, and building a core R & D in China", so as to stimulate the vitality of innovation, build a high-quality open innovation environment, actively integrate into the global scientific and technological innovation network, and promote more open, inclusive, mutually beneficial and shared international scientific and technological cooperation.